Upgrade to SI Premium - Free Trial

Tonix Pharma (TNXP)

10.59 -0.97 (8.39%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Tonix Pharmaceuticals CMO to retire in August 2026 July 21, 2026 4:08 PM - StreetInsider Form 8-K Tonix Pharmaceuticals For: Jul 20 July 21, 2026 4:06 PM - SEC Filing Raymond James sees potential for beats across biopharma coverage July 21, 2026 6:12 AM - StreetInsider Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models July 15, 2026 9:05 AM - StreetInsider Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models July 15, 2026 9:05 AM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: Jul 13 July 13, 2026 7:06 AM - SEC Filing Tonix secures Medicare payer deal for TONMYA, expanding coverage to 46% July 13, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA® July 13, 2026 7:00 AM - Globe NewsWire Form 4 Tonix Pharmaceuticals For: Jun 30 Filed by: SAENGER BRADLEY July 9, 2026 9:06 AM - SEC Filing Form S-8 Tonix Pharmaceuticals July 1, 2026 5:01 PM - SEC Filing Tonix enrolls first patient in Phase 2 MDD study of TNX-102 SL June 29, 2026 7:25 AM - StreetInsider Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD) June 29, 2026 7:25 AM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: Jun 29 June 29, 2026 7:06 AM - SEC Filing Raymond James Starts Tonix Pharma (TNXP) at Strong Buy June 24, 2026 4:24 PM - StreetInsider Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC June 15, 2026 5:44 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: Jun 12 Filed by: Taylor Carolyn E. June 15, 2026 7:00 AM - SEC Filing Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026 June 11, 2026 7:00 AM - Globe NewsWire Form 4 Tonix Pharmaceuticals For: Jun 09 Filed by: LEDERMAN SETH June 9, 2026 5:30 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: Jun 08 Filed by: Stillwell Richard Newcomb June 9, 2026 5:30 PM - SEC Filing Form 8-K Tonix Pharmaceuticals For: Jun 08 June 8, 2026 7:05 AM - SEC Filing Tonix Pharmaceuticals expands TONMYA coverage to 52 million lives June 8, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives June 8, 2026 7:00 AM - Globe NewsWire Tonix Pharmaceuticals presents fibromyalgia opioid use data at medical meeting May 28, 2026 4:31 PM - StreetInsider Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meet May 28, 2026 4:30 PM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: May 27 May 27, 2026 7:06 AM - SEC Filing Tonix publishes phase 1 data for TNX-1500 transplant rejection drug May 27, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology May 27, 2026 7:00 AM - Globe NewsWire Tonix presents fibromyalgia patient data at ISPOR meeting May 26, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2 May 26, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: Point72 Asset Management, L.P. May 15, 2026 4:30 PM - SEC Filing Form 8-K Tonix Pharmaceuticals For: May 15 May 15, 2026 9:26 AM - SEC Filing Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: Sirenia Capital Management LP May 15, 2026 8:06 AM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Stillwell Richard Newcomb May 14, 2026 5:49 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: OLUKOTUN ADEOYE Y May 14, 2026 5:48 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Bell Margaret Smith May 14, 2026 5:47 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Hunter James Randolph Jr May 14, 2026 5:46 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Treco James May 14, 2026 5:46 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: GRANGE DAVID L May 14, 2026 5:44 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: BAGGER RICHARD H May 14, 2026 5:43 PM - SEC Filing Form 4 Tonix Pharmaceuticals For: May 12 Filed by: Taylor Carolyn E. May 14, 2026 5:42 PM - SEC Filing Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026 May 14, 2026 7:00 AM - Globe NewsWire Tonix Pharmaceuticals to Participate in Two Investor Conferences in May May 12, 2026 4:30 PM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: May 11 May 11, 2026 5:18 PM - SEC Filing Form 10-Q Tonix Pharmaceuticals For: Mar 31 May 11, 2026 5:16 PM - SEC Filing Tonix Pharma (TNXP) Misses Q1 EPS by 35c May 11, 2026 4:33 PM - StreetInsider Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights May 11, 2026 4:30 PM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: May 07 May 7, 2026 5:21 PM - SEC Filing Form 8-K Tonix Pharmaceuticals For: May 06 May 6, 2026 7:06 AM - SEC Filing Tonix secures coverage for fibromyalgia drug for 35 million patients May 6, 2026 7:01 AM - StreetInsider Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients May 6, 2026 7:00 AM - Globe NewsWire TD Cowen Starts Tonix Pharma (TNXP) at Buy May 4, 2026 5:30 AM - StreetInsider Form 8-K Tonix Pharmaceuticals For: May 01 May 1, 2026 4:58 PM - SEC Filing Form 8-K Tonix Pharmaceuticals For: Apr 29 April 29, 2026 7:05 AM - SEC Filing Tonix plans phase 2 study of lyme disease prevention drug by 2027 April 29, 2026 7:00 AM - StreetInsider Tonix plans Phase 2 study of Lyme disease prevention drug TNX-4800 April 29, 2026 7:00 AM - StreetInsider Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at th April 29, 2026 7:00 AM - Globe NewsWire Form 8-K Tonix Pharmaceuticals For: Apr 21 April 23, 2026 7:12 AM - SEC Filing Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026 April 23, 2026 7:02 AM - Globe NewsWire Full Article List